2 recruiting, 1 unknown. 2 Phase 2, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Recruiting 1, Unknown 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow DA-EPOCH: new trials by email Literature Review of DA-EPOCH trials Research Report on DA-EPOCH
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Comparison Study of EAP and Disease-Specific Chemotherapy Regimens in Hematopoietic Stem Cell Mobilization for Lymphoma Etoposide, Cytarabine, PEG-rhG-CSF - Non-Hodgkin's Lymphoma, Hematopoietic Stem Cell Mobilization | Phase 3 | Recruiting | The Affiliated People's Hospital of Ningbo University | 99 | 2024-08-01 | 2025-12-04 |
| Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma DA-EPOCH, Rituximab, CHOP - Non-Hodgkin's Lymphoma, Diffuse Large B-Cell Lymphoma | Phase 2 | Recruiting | National Cancer Institute (NCI) | 132 | 2019-08-05 | 2026-10-26 |
| Trial of DA-EPOCH Regimen for NHL With HLH DA-EPOCH - NHL With Hemophagocytic Lymphohistiocytosis | Phase 2 | Unknown | The First Affiliated Hospital with Nanjing Medical University | 50 | 2012-06-01 | 2019-02-15 |
Lymphoma, Non-Hodgkin (3) · Lymphohistiocytosis, Hemophagocytic (1) · Lymphoma, Large B-Cell, Diffuse (1)
National Cancer Institute (NCI) (1) · The Affiliated People's Hospital of Ningbo University (1) · The First Affiliated Hospital with Nanjing Medical University (1)
China (2) · United States (1)
Christopher J Melani, M.D. (1) · Peipei Ye (1) · Wei Xu, M.D., Ph.D. (1)